IRF9在APL中低表达且与预后不良相关,提示存在特异性调控机制;上调IRF9表达可发挥抗白血病效应,为其成为临床潜在治疗靶点奠定生物学基础。. This evidence concerns the gene IRF9 and acute promyelocytic leukemia.